Spago Nanomedical AB is a Swedish company performing research and development within nanomedicine. Focus is the development of nanomaterials for tumor diagnostics and treatment of cancer. The main development projects SpagoPix and Tumorad are both built on proprietary nanomaterials

Key Facts Spago Nanomedical

• Founded in 2007
• Traded on the stock market (AktieTorget) since 2013
• Innovative team with expert capabilities in chemistry and nanoscale life science research
• Promising development projects within tumor diagnostics and therapeutics
• SpagoPix – nanomedical MRI contrast agent for tumor selective imaging
• Tumorad – nanomedical therapeutic agent for internal tumor selective radiotherapy
• Board of directors with extensive experience in contrast media- and pharma industry
• Based in Lund, Sweden